A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.

MLA

Ogawa, Yoshiaki, et al. “A Multicenter, Single-Arm, Phase II Clinical Trial of Bendamustine Monotherapy in Patients with Chronic Lymphocytic Leukemia in Japan.” International Journal of Hematology, vol. 105, no. 5, May 2017, pp. 631–37. EBSCOhost, https://doi.org/10.1007/s12185-016-2178-9.

APA

Ogawa, Y., Izutsu, K., Kiguchi, T., Choi, I., Takatsuka, Y., Ando, K., & Suzumiya, J. (2017). A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan. International Journal of Hematology, 105(5), 631–637. https://doi.org/10.1007/s12185-016-2178-9

Chicago

Ogawa, Yoshiaki, Koji Izutsu, Toru Kiguchi, Ilseung Choi, Yoshifusa Takatsuka, Kiyoshi Ando, and Junji Suzumiya. 2017. “A Multicenter, Single-Arm, Phase II Clinical Trial of Bendamustine Monotherapy in Patients with Chronic Lymphocytic Leukemia in Japan.” International Journal of Hematology 105 (5): 631–37. doi:10.1007/s12185-016-2178-9.